Global health agencies announced Wednesday that generic versions of a groundbreaking injectable drug to prevent HIV will be ...

This antiretroviral has shown unprecedented results in HIV prevention, requiring only two injections per year. Its ...

Lenacapavir, approved by the FDA in June, requires only two shots a year. US insurers don't cover it, but access will soon ...

The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir ...

The two organizations have signed separate agreements with Indian pharmaceutical companies to produce cheaper generics of lenacapavir - a twice-yearly injection shown to reduce the risk of HIV ...

Generic versions of a breakthrough injectable HIV-prevention drug will be made available for just $40 annually across 120 low- and middle-income countries starting in 2027, according to Unitaid and ...

Generic versions of a groundbreaking injectable HIV-prevention drug should be available for $40 a year in more than 100 ...

Stigma and lack of support hinder PrEP use among Black women; clinician bias and discrimination worsen disparities.

The Herald (Top Stories) Robin Muchetu, Health and Gender Editor ZIMBABWE will beginning next year introduce a bi-annual long-acting injectable HIV prevention drug, Lenacapavir, aimed at preventing ...

It's time to develop more effective ways to control and prevent sexually transmitted gut infections, urge the authors of an ...

A multi-institutional team led by Weill Cornell Medicine investigators has been awarded a five-year, $20.8 million grant from ...